Nykredit A S Makes New $280.21 Million Investment in CVS Health Corporation $CVS

Nykredit A S acquired a new stake in shares of CVS Health Corporation (NYSE:CVS) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 2,708,631 shares of the pharmacy operator’s stock, valued at approximately $280,208,000. CVS Health accounts for about 0.9% of Nykredit A S’s investment portfolio, making the stock its 17th largest position.

A number of other large investors also recently modified their holdings of CVS. Kilter Group LLC purchased a new stake in CVS Health in the 2nd quarter worth $27,000. Beaird Harris Wealth Management LLC boosted its stake in shares of CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock worth $30,000 after acquiring an additional 195 shares during the period. J.Safra Asset Management Corp purchased a new stake in shares of CVS Health during the second quarter worth about $30,000. Dunhill Financial LLC purchased a new position in CVS Health in the 2nd quarter worth approximately $32,000. Finally, Swiss RE Ltd. bought a new position in CVS Health in the 4th quarter worth approximately $26,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

NYSE:CVS opened at $97.20 on Thursday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The stock’s 50 day simple moving average is $101.09 and its two-hundred day simple moving average is $89.96. The company has a market cap of $124.31 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 0.95 and a beta of 0.59.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The firm had revenue of $106.10 billion during the quarter, compared to the consensus estimate of $100.03 billion. During the same period in the prior year, the company earned $1.81 EPS. The company’s quarterly revenue was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts anticipate that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is presently 70.37%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on CVS shares. JPMorgan Chase & Co. increased their price objective on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Robert W. Baird set a $107.00 target price on shares of CVS Health in a report on Thursday, August 6th. TD Cowen raised their target price on shares of CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Wells Fargo & Company lifted their price target on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Finally, Morgan Stanley boosted their price target on shares of CVS Health from $106.00 to $111.00 and gave the stock an “overweight” rating in a research note on Thursday, June 4th. Twenty-two equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.